Growing Public Awareness Will Uplift the Global Stem Cell Umbilical Cord Blood Market Through 2019: Technavio

LONDON--()--Technavio has published a new report on the global stem cell umbilical cord blood market, which is expected to grow at a CAGR exceeding 30% from 2015-2019.

About the Report

In accordance with the latest report by Technavio, UCB stem cells are proven to be an effective treatment option for more than 80 diseases, such as cancer, immunodeficiency disorders, and blood disorders.

“An abundance of research is being carried out for the development of UCB stem cells as an effective treatment option for diseases such as diabetes, Alzheimer's disease, brain tumors, and heart failure,” says Faisal Ghaus, Vice President of Technavio.

The latest report by Technavio also highlights the increasing public awareness of stem cell UCB banking, which is driven by the various awareness programs conducted.

“To increase the awareness of cord blood banking, Save the Cord Foundation is partnering with Bioinformant, and companies such as Americord and Viacord are promoting July as National Stem Cell Awareness month,” says Ghaus.

Market Scope and Calculation of Market Size

The new Technavio report covers the present scenario and growth prospects of the global stem cell umbilical cord blood market from 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.

Key Information Covered in the Report:

  • Key Vendors:
    • Caladrius Biosciences
    • Celgene Corporation
    • Mesoblast Ltd.
    • Pluristem Therapeutics
  • Market Growth Drivers:
    • Effective Treatment of Life-threatening Diseases
    • For a full detailed list, view our report.
  • Market Challenges:
  • Market Trends:

Technavio currently has more than 3000 market research reports on a huge range of topics, including 50+ reports on the stem cells market:

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
US: +1-630-333-9501
UK: +44-208-123-1770
Media & Marketing Executive
www.technavio.com
media@technavio.com

Release Summary

Technavio has published a new report on the global stem cell umbilical cord blood market, which is expected to grow at a CAGR exceeding 30% from 2015-2019.

Contacts

Technavio Research
Jesse Maida
US: +1-630-333-9501
UK: +44-208-123-1770
Media & Marketing Executive
www.technavio.com
media@technavio.com